Literature DB >> 28271228

Comparison of ease of administration of intranasal midazolam spray and oral midazolam syrup by parents as premedication to children undergoing elective surgery.

Milthi Manoj1, M V S Satya Prakash2, Srinivasan Swaminathan1, Rithu Krishna Kamaladevi1.   

Abstract

BACKGROUND: The efficacy of midazolam as premedication in children for providing pre-operative sedation and reducing parental separation anxiety has been well established. Many studies have compared the effectiveness and medication acceptance of midazolam via oral and intranasal routes. In this study, we have compared the ease of administration of oral midazolam syrup and intranasal midazolam spray as premedication, administered by parents to children.
METHODS: Ninety children were randomly allocated into one of the two groups: group N received nasal midazolam spray 0.2 mg/kg and group O received oral midazolam syrup 0.5 mg/kg administered by the parent. The parent recorded ease of administration score and facial hedonic score. The observer recorded modified medication acceptance score. Vitals and sedation scores were assessed at specific intervals. Thirty minutes after drug administration the child was separated from the parent, and parental separation anxiety score was recorded. Mask acceptance score was recorded after application of mask upon arrival in the OT.
RESULTS: Oral midazolam syrup was found to have better ease of administration than intranasal midazolam spray as felt by the parent. Medication acceptance was better for oral midazolam. Both the groups had similar sedation scores at 15 and 30 min. Children in the oral group had a better reduction in parental separation anxiety at 30 min after drug administration and better mask acceptance than the nasal group.
CONCLUSION: Oral midazolam syrup is easier for parents to administer and has better medication acceptance in children when compared to intranasal midazolam spray.

Entities:  

Keywords:  Ease of administration; Midazolam; Parents; Premedication

Mesh:

Substances:

Year:  2017        PMID: 28271228     DOI: 10.1007/s00540-017-2330-6

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  17 in total

Review 1.  The management of preoperative anxiety in children: an update.

Authors:  M E McCann; Z N Kain
Journal:  Anesth Analg       Date:  2001-07       Impact factor: 5.108

2.  Preanesthetic sedation of preschool children using intranasal midazolam.

Authors:  N C Wilton; J Leigh; D R Rosen; U A Pandit
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892

3.  Intranasal midazolam for premedication of children undergoing day-case anaesthesia: comparison of two delivery systems with assessment of intra-observer variability.

Authors:  N Griffith; S Howell; D G Mason
Journal:  Br J Anaesth       Date:  1998-12       Impact factor: 9.166

4.  Oral versus intranasal midazolam premedication for infants during echocardiographic study.

Authors:  Selman Vefa Yildirim; Belgin Usta Guc; Nesrin Bozdogan; Kursad Tokel
Journal:  Adv Ther       Date:  2006 Sep-Oct       Impact factor: 3.845

Review 5.  Evidence-based clinical update: does premedication with oral midazolam lead to improved behavioural outcomes in children?

Authors:  Robin G Cox; Ulyana Nemish; Alastair Ewen; Marie-Josée Crowe
Journal:  Can J Anaesth       Date:  2006-12       Impact factor: 5.063

6.  Oral midazolam preanesthetic medication in pediatric outpatients.

Authors:  L H Feld; J B Negus; P F White
Journal:  Anesthesiology       Date:  1990-11       Impact factor: 7.892

7.  Infant acceptance and effectiveness of a new oral liquid medication delivery system.

Authors:  D M Kraus; L A Stohlmeyer; P R Hannon
Journal:  Am J Health Syst Pharm       Date:  1999-06-01       Impact factor: 2.637

8.  A randomized clinical trial comparing oral, aerosolized intranasal, and aerosolized buccal midazolam.

Authors:  Eileen J Klein; Julie C Brown; Ana Kobayashi; Daniel Osincup; Kristy Seidel
Journal:  Ann Emerg Med       Date:  2011-10       Impact factor: 5.721

9.  Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes.

Authors:  H W Karl; J L Rosenberger; M G Larach; J M Ruffle
Journal:  Anesthesiology       Date:  1993-05       Impact factor: 7.892

10.  Plasma concentrations of midazolam in children following intranasal administration.

Authors:  E J Walbergh; R J Wills; J Eckhert
Journal:  Anesthesiology       Date:  1991-02       Impact factor: 7.892

View more
  2 in total

1.  Randomized clinical trial on the efficacy of intranasal or oral ketamine-midazolam combinations compared to oral midazolam for outpatient pediatric sedation.

Authors:  Joji Sado-Filho; Karolline Alves Viana; Patrícia Corrêa-Faria; Luciane Rezende Costa; Paulo Sucasas Costa
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

2.  The optimal dose of oral midazolam with or without intranasal S-ketamine for premedication in children: a randomised, double blinded, sequential dose-finding trial.

Authors:  Yong Bian; Siyi Zhou; Huiyan Hou; Tao Xu; Yue Huang
Journal:  Transl Pediatr       Date:  2021-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.